Katsuya Hirano

1PUBLICATIONS
2CO-AUTHORS
Predictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (1)

|Aug 01, 2019
Clinical outcomes in non-small cell lung cancer patients with an ultra-high expression of programmed death ligand-1 treated using pembrolizumab as a first-line therapy: A retrospective multicenter cohort study in Japan.

Ryuya Edahiro, Masaki Kanazu, Hiroyuki Kurebe

Pageof 1

Frequent Collaborators

1 joint publications

Ryuya Edahiro

1 joint publications

Masaki Kanazu